Scalable Solutions For High Potent OSD Manufacturing

Manufacturing oral solid dose products with highly potent APIs requires a disciplined balance of containment, process control, and regulatory rigor. As potency increases and OELs decrease, risks extend across dispensing, processing, packaging, and quality control — making end‑to‑end containment essential.

This asset explores how scalable high‑potent OSD manufacturing can be achieved through closed systems, advanced HVAC design, and validated cleaning strategies that protect operators while maintaining product integrity. It highlights practical approaches to managing both small‑scale development and commercial production, including flexible batch sizing, automated equipment, and robust dry granulation technologies designed to minimise dust generation and manual handling. Emphasis is placed on seamless tech transfer and reproducibility, ensuring processes developed at early phase can transition reliably to commercial scale without compromising safety or compliance.

For teams developing or scaling potent compounds, the content provides a clear view of how infrastructure, expertise, and process design come together to support predictable, compliant manufacturing.

Explore the full asset to see how high‑potency challenges can be addressed with confidence.